A great proportion of adults with hypertension, diabetes Mellitus and/or chronic kidney disease (CKD) are currently treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers. This evidence concerns the gene ACE and hypertensive disorder.